C-Reactive Protein and Fever in Neutropenic Patients

REFERENCES

• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54.
   PubMed Web of Science ®Google Scholar
• Hansson LO, Lindquist L. C-reactive protein: its role in the diagnosis and follow-up of infectious diseases. Curr Opin Inf Dis 1997; 10: 196–201.
   Google Scholar
• Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114–21.
   PubMed Web of Science ®Google Scholar
• Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transpl 1998; 22: 79–85.
   Google Scholar
• Rintala E, Remes K, Salmi TT, Koskinen P, Nikoskelainen J. The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation. Infection 1997; 25: 335–8.
   Google Scholar
• Rintala E, Irjala K, Nikoskelainen J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1992; 11: 973–8.
   PubMed Web of Science ®Google Scholar
• Schwaighofer H, Herold M, Schwarz T, Nordberg J, Ceska M, Prior C, et al. Serum levels of Interleukin 6, Interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation. Transplantation 1994; 58: 430–6.
   PubMedGoogle Scholar
• Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998; 26: 213–21.
   PubMed Web of Science ®Google Scholar
• Walker SA, Rogers TR, Riches PG, White S, Hobbs JR. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: early transplant period. J Clin Pathol 1984; 37: 1018–21.
   Google Scholar
• Rowe IF, Worsley AM, Donnelly P, Catovsky D, Goldman JM, Galton DAG, et al. Measurement of serum C-reactive protein concentration after bone marrow transplantation for leukemia. J Clin Pathol 1984; 37: 263–6.
   PubMedGoogle Scholar
• Saarinen UM, Strandjord SE, Warkentin PI, Cheung NKV, Lazarus HM, Coccia PF. Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients. Transplantation 1987; 44: 540–6.
   PubMedGoogle Scholar
• De Bel C, Gerritsen E, de Maaker G, Moolenaar A, Vossen J. C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation. Infection 1991; 19: 92–6.
   Google Scholar
• Ligtenberg PC, Hoepelman IM, Oude Sogtoen GAC, Dekker AW, van der Tweel I, Rozenberg-Arska M, et al. C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients. Eur J Clin Microbiol Infect Dis 1991; 10: 25–31.
   Google Scholar
• Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PEC, Liu Yin JA. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993; 12: 331–6.
   PubMed Web of Science ®Google Scholar
• Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Hematol 1993; 51: 102–8.
   PubMed Web of Science ®Google Scholar
• Lange A, Karabon L, Klimczak A, Dlubek D, Bogunia-Kubik K, Swider C, et al. Serum interferon-γ and C-reactive protein levels as predictors of acute graft-versus-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients. Transplant Proc 1996; 28: 3522–5.
   Google Scholar
• Passweg JR, Gratwohl A, Tichelli A, Hoffmann T, Kühne T, Favre G, Nissen C, Herrmann R, Cornu P, Osterwalder B, Schifferli JA, Signer E, Speck B. 25 Jahre Allogene Knochenmarkstransplantation in Basel: 1973–1998. Schweizerische Medizinische Wochenschrift 1998; 128: 1568–74.
   Google Scholar
• Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–32.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Meeting report: Consensus conference on acute GVHD grading. Bone Marrow Transpl 1995; 15: 825–8.
   PubMed Web of Science ®Google Scholar
• Cometta A, Calandra T, Gaya H, Zinner SH, De Bock R, Del Favero A, et al., and the International Antimicrobiol Therapy Cooperative Group of the EORTC and the GIMEMA Infection Program. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytic patients with cancer. Antimicrob Agents Chemother 1996; 40: 1108–15.
   Google Scholar
• Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, et al. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clin Inf Dis 1997; 24: 41–51.
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
   PubMed Web of Science ®Google Scholar
• Ferrara JLM. Pathogenesis of graft-versus-host disease and graft-host tolerance. In: Atkinson K, ed. Clinical bone marrow transplantation. Cambridge: Cambridge University Press, 1994: 52–61.
   Google Scholar
• Sullivan KM. Graft-versus-host disease. In: Forman SJ, ed. Bone marrow transplantation. Oxford: Blackwell Scientific Publications, 1994: 339–62.
   Google Scholar
• Sullivan KM, Deeg HJ, Sanders J, Klosterman A, Amos D, Shulman H, et al. Hyperacute GvHD in patients not given immunosuppression after allogeneic bone marrow transplantation. Blood 1986; 67: 1172–5.
   PubMedGoogle Scholar
• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–40.
   PubMed Web of Science ®Google Scholar